{
  "id": 6282135,
  "title": "Nanochon Performs First Case in the Chondrograft™ First-in-Human Clinical Study",
  "url": "https://urgent.news/2026/09/08/nanochon-performs-first-case-in-the-chondrografttm-first-in-human",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-08T13:47:11.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/pmn/business-wire-news-releases-pmn/nanochon-performs-first-case-in-the-chondrograft-first-in-human-clinical-study"
  },
  "original_language": "en",
  "account": null,
  "summary": "WASHINGTON — Nanochon, a medical device company developing Chondrograft™, a novel 3D-printed patented implant for the treatment of articular cartilage defects of the knee, today announced the successful treatment of the first patient in its First-in-Human (FIH) clinical study. The study is designed to evaluate the safety and performance of Chondrograft™ in patients with focal […]",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}